RxEars Rxi vs Yeasound RIC800

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it represents one of the most affordable options in the prescription hearing aid category while still delivering solid overall performance. Speech clarity is a notable strength for this device. In quiet listening environments, the Rxi scores 4.3/5, which is 0.97 points above the category average—a strong result that should benefit users in conversational settings at home or in calm environments. Speech understanding in noisy conditions scores 2.1/5, slightly above the category average by 0.16 points, though this remains mixed in absolute terms and may present challenges in demanding acoustic situations like busy restaurants. Feedback handling is excellent at 4.7/5, essentially matching the category average and indicating reliable stability during daily wear. However, the Rxi shows notable limitations in other areas. Own-voice comfort scores 1.6/5, falling 1.15 points below the category average, which may result in a hollow or boomy perception of your own voice. Music streaming is not supported, scoring 0.0/5—a significant gap of 2.64 points below category average that buyers should consider if streaming audio matters to them. The RxEars Rxi is best suited for budget-conscious consumers who prioritize speech clarity in quieter environments and don't require streaming capabilities. Its invisible form factor and disposable battery design offer convenience, though those seeking better own-voice comfort or music features should explore alternatives.

The Yeasound RIC800 is a mid-priced OTC hearing aid that earned an A grade with a SoundScore of 4.8/5 in our lab testing, placing it #2 among 65 OTC devices tested. At $659, this behind-the-ear rechargeable device delivers performance that significantly outpaces the category average of 3.71/5. Speech clarity is a standout strength. The RIC800 scores 4.4/5 for speech in quiet—a strong result that sits 1.63 points above the OTC category average. Speech in noise performance is more mixed at 2.4/5, though this still lands 0.93 points above the typical OTC device. Music streaming is where this device truly excels, scoring 4.3/5 and outperforming the category average by a substantial 2.38 points—making it one of the better choices for consumers who frequently stream audio from their phone. Feedback handling is excellent at 5.0/5, meaning users shouldn't encounter whistling issues during normal wear. The tradeoff comes with own-voice comfort, which scores 2.1/5—a mixed result that falls 0.41 points below the category average. Some users may notice their own voice sounds more hollow or boomy than expected. The RIC800 earned a 2025 Expert's Choice Award and supports both iPhone and Android streaming. For consumers seeking strong speech performance and exceptional streaming quality in the OTC space, this device represents a compelling option. Those particularly sensitive to own-voice quality may want to compare alternatives, but overall performance places the RIC800 among the top tier of OTC hearing aids we've tested.